Mycophenolate mofetil Tablet/Capsule

DRUG2 trials

Sponsors

Chong Kun Dang Pharmaceutical

Conditions

Heart TransplantKidney Transplant

Phase 4

MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients

CompletedNCT06044493

Chong Kun Dang PharmaceuticalKidney Transplant

Start: 2023-11-14End: 2025-10-29Updated: 2026-04-15

Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea

Not yet recruitingNCT06942156

Chong Kun Dang PharmaceuticalHeart Transplant

Start: 2025-08-14End: 2030-12-31Target: 140Updated: 2025-04-24